CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-21 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 201,562 | ||
| 2026-10-20 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-20 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,781 | $24.53 | $289K | 377,902 |
| 2026-10-20 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −100 | $24.85 | $2K | 377,802 |
| 2026-10-20 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 213,443 | ||
| 2026-10-19 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-19 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $24.05 | $286K | 377,802 |
| 2026-10-19 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 225,324 | ||
| 2026-10-16 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-16 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,581 | $24.21 | $280K | 378,102 |
| 2026-10-16 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −300 | $25.45 | $8K | 377,802 |
| 2026-10-16 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 237,205 | ||
| 2026-10-15 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-15 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $25.61 | $304K | 377,802 |
| 2026-10-15 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 249,086 | ||
| 2026-10-14 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-14 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −6,781 | $25.57 | $173K | 382,902 |
| 2026-10-14 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −5,100 | $25.82 | $132K | 377,802 |
| 2026-10-14 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 260,967 | ||
| 2026-10-13 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
Page 4 of 119 · 2,375 trades